Home › NDC Lookup › RxCUI directory › RxCUI 402012

Risperidone 50 MG Injection — RxCUI 402012

RxNorm drug concept · Semantic clinical drug
RxCUI 402012 Semantic clinical drug · SCD ● Current RxNorm concept 18 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI402012
Official nameRisperidone 50 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrisperiDONE 50 MG Extended Release Injection
FDA products mapped18
Package NDCs mapped16
Reported Medicaid activity (SDUD)44,565 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Risperidone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injectable form gives you a steady, consistent level of medication over weeks — so you don't have to remember a daily pill. This can make a big difference in keeping symptoms u...
  • Why is my doctor using an injection instead of a pill?
  • It depends on the specific product your doctor prescribes. With some formulations, your doctor will have you take oral risperidone for about three weeks after your first injection...
  • Will I need to take anything by mouth when I first start the injection?
📖 Read our full Risperidone Injection guide →

🕸️ Concept Web — How Risperidone 50 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Risperidone 50 MG Injection RxCUI 402012

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Risperidone 35636
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Risperdal 152318
    • Rykindo 2639728
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Risperidone Injection 1743574
    • Risperidone Injectable Product 1165478
    • Risperidone Injection [Risperdal] 1743577
    • Risperidone Injection [Rykindo] 2639731
    • Risperdal Injectable Product 1185339
    • Rykindo Injectable Product 2639730
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Risperidone 50 MG SCDC · 1743583
  • Risperidone Injection SCDF · 1743574
  • Risperidone Injectable Product SCDG · 1165478

Brand-Name Concepts

  • Risperidone 50 MG Injection [Risperdal] SBD · 706829
  • Risperidone 50 MG Injection [Rykindo] SBD · 2639738
  • Risperidone 50 MG [Risperdal] SBDC · 1743585
  • Risperidone 50 MG [Rykindo] SBDC · 2639737
  • Risperidone Injection [Risperdal] SBDF · 1743577
  • Risperidone Injection [Rykindo] SBDF · 2639731
  • Risperdal Injectable Product SBDG · 1185339
  • Rykindo Injectable Product SBDG · 2639730
  • Risperdal BN · 152318
  • Rykindo BN · 2639728

📦 FDA Products & Package NDCs

18 products · 16 package NDCs
16 package NDCs map to RxCUI 402012 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00480-1232-08 1 KIT in 1 CARTON (0480-1232-08) * 2 mL in 1 VIAL (0480-97... Risperidone Teva Pharmaceuticals, Inc. 2023-12-11
00480-1342-08 1 KIT in 1 CARTON (0480-1342-08) * 2 mL in 1 VIAL (0480-97... Risperidone Teva Pharmaceuticals, Inc. 2023-12-11
00480-1453-08 1 KIT in 1 CARTON (0480-1453-08) * 2 mL in 1 VIAL (0480-97... Risperidone Teva Pharmaceuticals, Inc. 2023-12-11
00480-1554-08 1 KIT in 1 CARTON (0480-1554-08) * 2 mL in 1 VIAL (0480-97... Risperidone Teva Pharmaceuticals, Inc. 2023-12-11
50458-0306-11 1 KIT in 1 BOX (50458-306-11) * 2 mL in 1 SYRINGE (50458-3... RISPERDAL CONSTA Janssen Pharmaceuticals, Inc. 2003-10-29
50458-0307-11 1 KIT in 1 BOX (50458-307-11) * 2 mL in 1 VIAL * 2 mL in... RISPERDAL CONSTA Janssen Pharmaceuticals, Inc. 2003-10-29
50458-0308-11 1 KIT in 1 BOX (50458-308-11) * 2 mL in 1 VIAL * 2 mL in... RISPERDAL CONSTA Janssen Pharmaceuticals, Inc. 2003-10-29
50458-0309-11 1 KIT in 1 BOX (50458-309-11) * 2 mL in 1 VIAL * 2 mL in... RISPERDAL CONSTA Janssen Pharmaceuticals, Inc. 2003-10-29
70121-2625-05 1 KIT in 1 CARTON (70121-2625-5) * 2 mL in 1 VIAL (70121-1... Risperidone Amneal Pharmaceuticals LLC 2025-09-08
70121-2626-05 1 KIT in 1 CARTON (70121-2626-5) * 2 mL in 1 SYRINGE (7012... Risperidone Amneal Pharmaceuticals LLC 2025-09-08
70121-2627-05 1 KIT in 1 CARTON (70121-2627-5) * 2 mL in 1 VIAL (70121-1... Risperidone Amneal Pharmaceuticals LLC 2025-09-08
70121-2628-05 1 KIT in 1 CARTON (70121-2628-5) * 2 mL in 1 VIAL (70121-1... Risperidone Amneal Pharmaceuticals LLC 2025-09-08
70748-0270-13 1 KIT in 1 BOX (70748-270-13) * 2 mL in 1 VIAL (70748-449-... risperidone Lupin Pharmaceuticals, Inc. 2025-10-17
70748-0271-13 1 KIT in 1 BOX (70748-271-13) * 2 mL in 1 VIAL (70748-450-... risperidone Lupin Pharmaceuticals, Inc. 2025-10-17
70748-0272-13 1 KIT in 1 BOX (70748-272-13) * 2 mL in 1 VIAL (70748-451-... risperidone Lupin Pharmaceuticals, Inc. 2025-10-17
72526-0102-11 1 KIT in 1 KIT (72526-102-11) * 2 mL in 1 VIAL, SINGLE-DOS... Rykindo extended-release microspheres Shandong Luye Pharmaceutical Co., Ltd. 2023-06-20
Observed labelers: Amneal Pharmaceuticals LLC (4) · Janssen Pharmaceuticals, Inc. (4) · Teva Pharmaceuticals, Inc. (4) · Lupin Pharmaceuticals, Inc. (3) · Shandong Luye Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2794 Inj risperdal consta, 0.5 mg 14 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.